In Brief: AbbVie’s Rinvoq Secures US Approval For Giant Cell Arteritis

Follows Recent EU Approval For Same Indication

 
• By Sushmita Panda

JAK inhibitor gains ninth indication in US after a strong performance in the first quarter.

AbbVie logo (Shutterstock)

More from Immunological

More from Scrip